SEC Form 4 · accession 0001179110-15-009833
Assertio Therapeutics, Inc · ASRT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Thadd M Vargas
Officer — Senior VP, BD
Period of report
Jun 12, 2015
Accepted (ET)
Jun 15, 2015 · 5:16 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001005201
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Comon StockF1 | Jun 12, 2015 | S | 5,000 | $20.70 | D | 138,153 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Shares were initially purchased under Depomed, Inc.'s 2004 Equity Incentive Plan.